Company Profile

MBF Bioscience (AKA: MBF Inc~Microbrightfield Inc~Microbrightfield LLC)
Profile last edited on: 1/11/2022      CAGE: 1CLS0      UEI: L5XGENY3LNN7

Business Identifier: Quantitative imaging software for stereology, neuron reconstruction, and image analysis
Year Founded
1988
First Award
1989
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

185 Allen Brook Lane Suite 101
Williston, VT 05495
   (802) 288-9290
   info@mbfbioscience.com
   www.mbfbioscience.com
Location: Multiple
Congr. District: 00
County: Chittenden

Public Profile

MBF Bioscience provides quantitative imaging software for stereology, neuron reconstruction, and image analysis that can be integrated with the world's leading microscope systems. The firm's services include design-based stereology, neuron reconstruction, brain mapping, virtual slides, autoradiography, and worm tracking. The firm provides fully integrated research systems and software-only solutions. Other services include Biolucida for Medical Education, Biolucida for Research, Biolucida for Publishers, Brain Mapping, Retinal Stimulation, Whole-Slide Imaging, Structured Illumination, and Densitometry. The firm's software allows you to easily obtain accurate quantitative measurements from microscope images, whether from brightfield, fluorescent, spinning disk, or laser-scanning confocal microscopes.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2024 2 NIH $2,985,146
Project Title: Microscope system for large scale optical imaging of neuronal activity using kilohertz frame rates
2023 2 NIH $2,750,791
Project Title: NeuroExM
2023 2 NIH $1,377,800
Project Title: Next generation axonal quantification and classification using AI
2023 2 NIH $1,449,826
Project Title: System for Volumetric 2-photon Imaging of Neuroactivity Using Light Beads Microscopy
2022 2 NIH $4,544,400
Project Title: ClearScope

Key People / Management

  Jacob R Glaser -- President

  Jeff H Sprenger -- President

  Paul Angstman -- Vice President

  Mark Barton -- Director of Sales and Marketing

  Edmund Glaser -- Co-Founder

  Nathan O'Connor -- Product Manager

  Susan Tappan -- Scientific Director

Company News